APR 12-13 2017 Opens: 6:00 AM PT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Molecular Diagnostics 2017
5 15 2220

Join LabRoots in bringing together the molecular diagnostics community. Attend webcasts with top experts and interact with speakers during the live Q&A sessions. Earn continuing education credits and network with peers. Enjoy the complementary conference from your desk with no need for travel, and explore the virtual exhibit hall to learn about the latest technologies and techniques for your lab.
The 2nd Annual Molecular Diagnostics Virtual Conference is the premiere venue for scientists, technologists, and professionals to discuss and present the newest advances in molecular diagnostics testing. Attend this online event at no charge.
Topics discussed in last year’s event included:

  • Regulations in Molecular Diagnostics Clinical Laboratory Testing
  • Inherited Genetic Disorders and Prenatal Applications in Modern Medicine
  • Next Generation Sequencing (NGS) in the Clinical Laboratory: Reality vs. Opportunity
  • Precision medicine in Oncology
  • Liquid Biospies: Applications in Molecular Diagnostics
  • Infectious Disease Screening, Diagnosis and Monitoring
  • Molecular Diagnostics Applications in Point of Care
  • Genomic Health

Call for Posters
Plan now to have your poster included in the international Molecular Diagnostics 2017 Virtual Event!
Learn More

Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global diagnostics community with a high degree of interaction through live-streaming video and chat sessions.

Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (CE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

Use #LRmoldx to follow the conversation

  • Principal at Roger D. Klein, MD JD Consulting, Cleveland Clinic, Chair, Professional Relations Committee, Association for Molecular Pathology (AMP); Medical Director, Molecular Oncology
  • Chief Medical Officer, Invitae
  • Icahn School of Medicine at Mount Sinai Departments of Genetics and Genomic Sciences, Pediatrics, Obstetrics/Gynecology & Reproductive Sciences and Oncological Sciences

Show Resources
All times are Pacific Time

  • Roger Klein MD, JD, FCAP
    Principal at Roger D. Klein, MD JD Consulting, Cleveland Clinic, Chair, Professional Relations Committee, Association for Molecular Pathology (AMP); Medical Director, Molecular Oncology
      Roger D. Klein, M.D., J.D., serves as Medical Director of Molecular Oncologyo at Bloodcenter Of Wisconsin, Inc. Dr. Klein lead the development of BloodCenter of Wisconsin's Diagnostic Laboratories' newest initiative, which will focus on DNA- and RNA-based testing for evaluation of cancer patients. Dr. Klein comes to BloodCenter from H. Lee Moffitt Cancer Center where he served as Medical Director of Molecular Diagnostics and was an Assistant Professor in the Department of Oncologic Sciences, at the University of South Florida Medical School in Tampa, FL. Dr. Klein's academic and clinical efforts focus on the translation of molecular genetic knowledge into clinical diagnostic tests. In addition, Dr. Klein has an active research program involving the ethical, legal and social implications (ELSI) of the Human Genome Project, with particular emphasis on the areas of intellectual property and the regulation of in vitro diagnostics and clinical laboratories. Dr. Klein is a member of the CDC's Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group and a consultant to the FDA's Clinical and Molecular Genetics Advisory Panel. He also serves on the College of American Pathologists' Molecular Oncology Resource Committee, and the Association for Molecular Pathology's Professional Relations and CPT Coding Committees. He completed residency training in Laboratory Medicine, together with fellowships in Medical Microbiology and Molecular Genetics, at Yale University School of Medicine in New Haven, CT, followed by a fellowship in Molecular Genetic Pathology at Mayo Clinic in Rochester, MN. In addition, Dr. Klein earned a law degree from Yale Law School. He is board-certified in Clinical Pathology and Molecular Genetic Pathology. Dr. Klein earned his medical degree and completed an internship in Internal Medicine at Case Western Reserve University in Cleveland, OH.
    • Robert Nussbaum MD, FACP, FACMG
      Chief Medical Officer, Invitae
        Dr. Nussbaum is currently the Chief Medical Officer of Invitae, a genetic information and diagnostic company. From 2006-2015, he was the Holly Smith Professor of Medicine at UCSF, Chief of the Division of Genomic Medicine, director of the Genomic Medicine Initiative at UCSF, and Medical Director of both the Cancer Risk Program at the Helen Diller Family Cancer Center and the UCSF Program in Cardiovascular Genetics, where he continues to see patients as a volunteer clinical faculty member. He came to UCSF in 2006 from the Division of Intramural Research of the National Human Genome Research Institute, NIH, where he served for 12 years as Chief of the Genetic Diseases Research and Inherited Disease Research Branches. Before his time at NIH, he was a faculty member in the Department of Genetics at the University of Pennsylvania and an Attending Physician at Children's Hospital of Philadelphia. He received his training in medicine in the Harvard-MIT Joint Program in Health Technology, his internal medicine training at Barnes Hospital/Washington University, and his genetics training at Baylor College of Medicine. He is board certified in internal medicine, clinical genetics and clinical molecular genetics. Dr. Nussbaum directed the original research that led to the discovery of mutations in -synuclein in hereditary Parkinson disease in the mid 1990's and studied its role in Parkinson disease for nearly 20 years. For his work on Parkinson disease, he was awarded the Klaus Joachim Zülch-Prize for Neurological Research and the Jay Van Andel Award for Outstanding Achievement in Parkinson's Disease Research. He also carried out positional cloning and characterization of the gene mutated in Lowe syndrome that led to accurate biochemical and molecular genetic testing, for which he has been recognized three times with awards from the Lowe Syndrome Association. He is the co-author of over 200 peer-reviewed publications on a broad range of topics in basic and applied human genetics and is co-author with Drs. Roderick M. McInnes and Huntington F. Willard of the popular textbook of human genetics, Thompson and Thompson's Genetics in Medicine. He has received numerous teaching awards from the University of Pennsylvania, the National Human Genome Research Institute and the University of California, San Francisco, and was awarded the Excellence in Education Award of the American Society of Human Genetics with his co-authors Drs. Willard and McInnes. Dr. Nussbaum is a Director and Treasurer of the American Board of Medical Genetics and Genomics and has served on the Board of Directors of the American College of Medical Genetics and Genomics and on the Board of the American Society of Human Genetics, where he also served as President. He was elected to the Institute of Medicine in 2004 and the American Academy of Arts and Sciences in 2015.
      • John Martignetti, MD, PhD
        Icahn School of Medicine at Mount Sinai Departments of Genetics and Genomic Sciences, Pediatrics, Obstetrics/Gynecology & Reproductive Sciences and Oncological Sciences
          John A. Martignetti, MD, PhD, an expert in human genetics and genomic sciences at the Icahn School of Medicine at Mount Sinai, as the Network Director of the Laboratory for Translational Research at the WCHN Biomedical Research Institute. Under this collaboration, Dr. Martignetti's well-established bedside to bench cancer research methodology will be extended to patients at Danbury, Norwalk and New Milford hospitals leading to more personalized and successful therapeutic strategies. He will work closely with the oncology physicians and research scientists across WCHN to build on their nationally recognized efforts.

        For information on becoming a sponsor or exhibitor, please click here.


        To download the Program Committee brochure here.

        • Bryan Cobb, PhD, FACMG

          Dr. Cobb is the acting Director for Clinical Molecular Diagnostics at Roche Diagnostics Corporation where he serves in a scientific advisory role supporting the laboratory scientific community. He obtained his Ph.D. in Medical Genetics at the University of Alabama at Birmingham ...

          Show more Show less
        • Shawn Baker, PhD

          Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...

          Show more Show less
        • Jason Alter, PhD

          Dr. Jason Alter is the Director of Clinical Genomic Affairs for GenomeDx Biosciences. He and his team specialize in the integration of advanced genomic testing with clinical practice. Jason has extensive experience in the field of prostate cancer prognostic assay development and ...

          Show more Show less
        • Martin Latterich, PhD

          The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

          Show more Show less
        • Judd Moul, MD, FACS

          Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

          Show more Show less
        • Emily Hollister, PhD

          Dr. Hollister is a microbial ecologist and bioinformaticist. She is interested in quantifying and characterizing microbial communities from a wide variety of environments, including the human body. Utilizing high throughput, next-generation DNA and RNA sequence approaches, her ...

          Show more Show less

        General LabRoots Questions

        For bugs, spam, technical support or questions please call +1-714-463-4673 or email [email protected]  
        Contact us

        Virtual Events and Webinars

        Supported Configurations

        • Operating System Internet Explorer Firefox Chrome Safari
          Vista IE8+ FF10+ Chrome15+
          Windows 7 IE8+ FF10+ Chrome15+
          Windows 8 IE10 FF10+ Chrome15+
          Mac OS X   FF10+ Chrome15+ Safari5.1+
        • Cookie settings: session cookies enabled
        • Browser configuration must have JavaScript enabled
        • Adobe Flash player 10.2 or later

        To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

        Internet Connection

        • A minimum of 100Kbps is recommended for audio-only events
        • A minimum of 300Kbps is recommended for speaker on-video events

        Computer Equipment

        • Screen Resolution: Minimum 1024x768
        • Video Card: 65,000 colors minimum
        • Sound card and speakers (or headphones) for hearing webcast in full format
        • Audio Card: 16-bit minimum
        • RAM: 512MB of free RAM

        Firewall Protocol

        • HTTP on port 80 or HTTPS on port 443
        • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
        • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

        Work-At-Home Attendees

        • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

        For A Seamless Experience

        When using a mobile device, FREE Mobile Apps are available:

        - For viewing Webinars:

        - For viewing Virtual Events

        Attendee Guide

        • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

        Virtual Event and Webinar Support:

        Continuing Education (CME/CE) Support

        Loading Comments...
        Show Resources
        Event Countdown
        • 0 Days
        • 0 Hours
        • 0 Minutes
        • 0 Seconds